ANDREW PONTERIO: Open Payments
NPI 1497108922 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,342 in 117 payments from 16 companies in 2025. Trend: 2023 $159 · 2024 $1,393 · 2025 $2,342
Food & beverage: $2,342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $848 |
| Eisai Inc. | 15 | $312 |
| Vanda Pharmaceuticals Inc. | 6 | $255 |
| Neurocrine BioSciences, Inc. | 10 | $185 |
| ACADIA Pharmaceuticals Inc | 6 | $160 |
| PFIZER INC. | 11 | $153 |
| Ipsen Biopharmaceuticals, Inc | 2 | $133 |
| SK Life Science, Inc. | 2 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $46 |
Products named: QULIPTA, Leqembi, PONVORY, UBRELVY, INGREZZA, NUPLAZID, Dysport, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
